Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice

Abstract

These findings suggest that, in the preclinical setting, EGFR-TKIs may have a protective effect on lung fibrosis induced by bleomycin. Because these molecular targeted drugs may have differing effects depending on species and individuals, a cautious interpretation is warranted.